We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

WW International, Inc

Company price
13.07 USD 0.02 ( 0.15%)
Last update at 2026-11-12T15:46:00Z
VOLUME
15688
Market Cap
151.28M
P/E
1.54

Momentum Score

…

WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
12.74
Low
13.11
High
52 Week Price Range
8.37
Low
38.38
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
13.05
Dividend Yield
-
Revenue TTM
665.49M
Revenue Per Share
66.60
Gross Profit TTM
472.64M
Debt / Equity
1.47
ROE
-30.71%
Net Debt
308.34M
ROCE
140.80%
Diluted EPS TTM
9.80

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Income before tax 1091.45M -345.18M -73.63M -365.78M -366.80M
Minority interest - - - 0.00M 0.00M
Net income 1056.01M -345.70M -112.25M -251.40M -256.87M
Selling general administrative 421.68M 175.67M 217.56M 263.84M 263.84M
Selling and marketing expenses 421.68M 236.47M 238.39M 244.78M 244.78M
Gross profit 510.50M 533.10M 529.30M 622.40M 621.38M
Reconciled depreciation 67.68M 37.78M 52.47M 43.80M 43.80M
Ebit 1154.86M -236.22M 22.26M 112.09M -285.66M
Ebitda 1222.54M -198.44M 74.73M 155.89M -241.86M
Depreciation and amortization 67.68M 37.78M 52.47M 43.80M 43.80M
Operating income 46.43M 78.81M 25.97M 112.09M -283.97M
Other operating expenses 664.20M 707.11M 863.59M 927.08M 1323.81M
Interest expense 63.41M 108.95M 95.89M 81.14M 81.14M
Tax provision 35.45M 0.53M 38.62M -114.38M -114.38M
Net interest income -63.41M -108.95M -95.89M -81.14M -81.14M
Income tax expense 35.45M 0.53M 38.62M -114.38M -109.94M
Total revenue 710.64M 785.92M 889.55M 1040.86M 1039.84M
Total operating expenses 464.06M 454.29M 503.34M 508.62M 905.35M
Cost of revenue 200.14M 252.82M 360.25M 418.46M 418.46M
Total other income expense net 1045.02M -423.99M -99.60M -477.87M -82.83M
Net income from continuing ops 1056.01M -345.70M -112.25M -251.40M -251.40M
Net income applicable to common shares - - - -251.40M -251.40M
Breakdown 2025-12-31 2024-12-31 2024-01-31 2023-12-31 2023-01-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2024-01-31 2023-12-31 2023-01-31
Total assets 946.76M 550.28M 982.03M 982.03M 1028.43M
Intangible assets 490.66M 115.76M 449.73M 449.73M 450.05M
Other current assets 36.95M 35.20M 55.10M 55.10M 38.76M
Total liab 628.69M 1664.65M 1743.12M 1743.12M 1712.24M
Total stockholder equity 318.07M -1114.37M -761.09M -761.09M -683.82M
Other current liab 81.49M 113.37M 143.37M 141.77M 127.56M
Common stock 378.78M - - - -
Capital stock 378.78M 0.00M 0.00M 0.00M 0.00M
Retained earnings -62.09M 1936.17M 2314.83M 2314.83M 2418.96M
Other liab - - - - 25.30M
Good will 200.13M 239.58M 243.44M 243.44M 156.00M
Other assets - - - - 34.67M
Cash 160.28M 53.02M 109.37M 109.37M 178.33M
Total current liabilities 126.54M 173.33M 205.46M 205.46M 196.56M
Current deferred revenue 28.57M 31.66M 33.97M 33.97M 32.16M
Net debt 308.34M 1430.11M 1380.18M 1380.17M 1330.01M
Short term debt 1.26M 8.17M 9.62M 9.61M 17.95M
Short long term debt total 468.62M 1483.13M 1489.54M 1489.54M 1508.34M
Other stockholder equity - -3024.71M -3064.63M -3064.63M -3097.30M
Property plant equipment - - - - 103.92M
Total current assets 213.60M 102.65M 179.47M 179.47M 281.33M
Net tangible assets - - - - -1289.86M
Short term investments - 70.64M 3.56M 3.56M -
Net receivables 16.38M 14.43M 14.94M 14.94M 24.27M
Long term debt 465.47M 1430.64M 1426.46M 1426.46M 1422.28M
Inventory - - 0.07M 0.07M 20.53M
Accounts payable 9.21M 17.80M 18.51M 18.51M 18.89M
Accumulated other comprehensive income 1.39M -25.83M -11.30M -11.30M -5.47M
Non currrent assets other 14.82M 17.75M 17.68M 17.68M 14.88M
Non current assets total 733.15M 447.63M 802.56M 802.56M 747.10M
Capital lease obligations 3.15M 52.49M 63.07M 63.07M 86.05M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-01-31 2022-12-31
Investments - -16.41M -74.70M -42.64M -42.64M
Change to liabilities - - - -14.42M -14.42M
Total cashflows from investing activities -19.50M -16.41M -74.70M -42.64M -42.64M
Net borrowings 171.34M 0.00M 0.00M - 0.00M
Total cash from financing activities 153.90M -17.34M -2.75M -4.72M -4.72M
Change to operating activities - - - 27.21M 27.21M
Net income 1056.01M -345.70M -112.25M -251.40M -256.87M
Change in cash 110.06M -52.85M -68.96M 24.53M 24.53M
Begin period cash flow 230.14M 109.37M 178.33M 153.79M 153.79M
End period cash flow 340.20M 56.52M 109.37M 178.33M 178.33M
Total cash from operating activities -28.90M -16.84M 6.69M 76.65M 76.65M
Depreciation 67.68M 37.78M 52.47M 43.80M 43.80M
Other cashflows from investing activities -0.00M -0.01M -0.03M -0.04M -0.04M
Change to inventory 0.01M 0.09M 14.02M 3.73M 3.73M
Change to account receivables 0.68M 1.60M 17.11M -7.56M -7.56M
Sale purchase of stock - -0.84M -2.24M - -2.20M
Other cashflows from financing activities -17.44M -17.34M -3.47M 1559.28M -4.72M
Change to netincome - - - 270.86M 270.86M
Capital expenditures 17.48M 16.41M 36.30M 38.25M 38.25M
Change in working capital -33.31M -11.52M 12.99M 8.38M 8.68M
Stock based compensation 4.64M 7.76M 15.19M 12.96M 12.96M
Other non cash items -1140.50M 294.83M 38.29M 413.91M 413.91M
Free cash flow -46.38M -33.25M -29.61M 38.39M 38.39M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
WW
WW International, Inc
0.02
0.15%
13.07 1.54 74.07 0.23 0.55 0.58 0.34
HCA
HCA Healthcare, Inc.
1.17
0.23%
507.21 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-1.82
0.62%
291.15 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.12
0.84%
14.84 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-
-%
5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

WW International, Inc

WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

18 West 18th Street, New York, NY, United States, 10011

212 589 2700

3500

Name Title Year Born
Mr. Michael Lysaght Chief Technology Officer 1974
Mr. Michael F. Colosi Gen. Counsel & Sec. 1966
Ms. Amy K. O'Keefe Exec. Officer 1972
Ms. Sima Sistani CEO & Director 1980
Ms. Heather Stark Interim Principal Financial Officer NA
Ms. Amy Kossover Chief Accounting Officer, Sr. VP & Corp. Controller 1962
Mr. Gary D. Foster Ph.D. Chief Scientific Officer NA
Ms. Corey Kinger VP of Investor Relations NA
Ms. Amanda Tolleson Chief Marketing Officer NA
Ms. Debra Benovitz Sr. VP of Global Insights & Innovation 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…